Medical research centers and public health: Review

Zahra Tolou-Ghamari

Abstract


It is well known that medical research should be able to make intense contributions regarding the care of patients, in addition to our understanding of the disease, the surgical process, and its outcome, and pharmacotherapy strategy. This study aimed to review medical research centers and public health. Based on the topic of study, the specific question was searched on the electronic databases of journals found on the Web of Science, Scopus, and PubMed. Medical research centers should move ahead toward the best pharmacotherapy outcomes for illnesses and diseases affecting millions of people worldwide. Based on new technology and highly expert researchers, the medical research centers could play an important role in enhancing our understanding to improve public health.  Its primary aim should be based on the expansion of scientific knowledge in medicine, pharmacology, and other associated areas. As a result, the efficacy and side effects of drugs, cancer treatment, precision medicine, the development of vaccines, and other related areas should be the main goals of medical research. To control the occurrence of disease, campaigns for smoking cessation, obesity supervision, drug adverse effects, and communicable diseases, these centers play an important role in identifying, analyzing, studying, and mentioning the associated risk factors.  As the medical research centers play an important role in advancing public health, the construction of medical research centers should be conducted with the patient and health system demands in mind. To make informed funding decisions, policymakers need to rely on research data.


Full Text:

PDF

References


Institute of Medicine (US) Clinical Research Roundtable. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Tunis S, Korn A, Ommaya A, editors. Washington (DC): National Academies Press (US); 2002.

https://en.wikipedia.org/wiki/Health_system.

"Everybody's business. Strengthening health systems to improve health outcomes : WHO's framework for action" (PDF). WHO. 2007. Archived (PDF) from the original on 28 December 2021. Retrieved 4 October 2020.

Bos D, Ikram MA. Research aims in clinical medicine: description, identification, or explanation. World Neurosurg 161:240-244, 2022.

Pinsky WW. The roles of research in an academic medical center. Ochsner J 2:201-202, 2000.

Falahat K, Eftekhari M, Habibi E, Djalalinia Sh, Peykari N, Owlia P, Malekafzali H, Ghanei M, Mojarrab Sh. Trend of knowledge production of research centers in the field of medical sciences in iran. Iran J Public Health 42(Supple1):55-59, 2013.

Vymĕtal J, Beran J. Vĕdecko-výzkumná a pedago-gická cinnost v oblasti humanitních vĕd na lékarských fakultách v Ceské republice [Scientific research and pedagogical activity in the field of humanistic sciences at medical schools in the Czech Republic]. Sb Lek 103:323-327, 2002.

Debov SS, Morozov BV. Itogi i perspektivy issledovaniĭ v oblasti fiziko-khimicheskoĭ biologii i biotekhnologii, provodimykh AMN SSSR [Results andoutlook of research in the field of physicochemical biology and biotechnology performed by the Academy of Medical Sciences of the USSR]. Vestn Akad Med Nauk SSSR 11:28-32, 1987. Russian.

Tolou-Ghamari Z. Review of association between urinary tract infections and immunosuppressive drugs after heart transplantation. Rev Recent Clin Trials 20:18-26, 2025.

Tolou-Ghamari Z. A review of the association between infections, seizures, and drugs. Cent Nerv Syst Agents Med Chem 25(1):49-55, 2025.

Tolou Ghamari Z, Palizban AA. Tacrolimus pharmacotherapy: Infectious complications and toxicity in organ transplant recipients; An updated review. Curr Drug Res Rev 17:301-310, 2025.

Tolou-Ghamari Z. Tacrolimus and cyclosporin pharmacotherapy, detection methods, cytochrome P450 enzymes after heart transplantation. Cardiovasc Hematol Agents Med Chem 22:106-113, 2024.

Tolou-Ghamari Z, Palizban AA. Laboratory monitoring of cyclosporine pre-dose concentration (C0) after kidney transplantation in Isfahan. IJMS 28: 81-85, 2003.

Tolou-Ghamari Z, Palizban AA, Tredger JM. Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs in R&D 5:17-22, 2004.

Shaygannejad V, Dehnavi SR, Ashtari F, Karimi S, Dehghani L, Meamar R, Tolou-Ghamari Z. Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population. Int J Prev Med 4(Suppl 2):S279-83, 2013.

Ghamari ZT. Prevalence of stomach cancer in Isfahan province, Iran. Gulf J Oncolog 1:42-45, 2018.

Tolou-Ghamari Z, Palizban AA, Michael Tredger J. Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs R& D 5:17-22, 2004.

Tolou-Ghamari Z, Palizban AA. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin.Saudi Med J 25:1499-500, 2004.

Tolou-Ghamari Z, Mortazavi M, Palizban AA, Najafi MR. The investigation of correlation between Iminoral concentration and neurotoxic levels after kidney transplantation. Adv Biomed Res 4:59, 2015.

Tolou-Ghamari Z. Tacrolimus, Cytochrome P450, interactions with food variables in organ transplant recipients; A current and comprehensive review. Curr Drug Metab 25:547-553, 2025.

Tolou-Ghamari Z. A Review of the association between infections, seizures, and drugs. Cent Nerv Syst Agents Med Chem 25:49-55, 2025.

https://en.wikipedia.org/wiki/Isfahan_University_of_Medical_Sciences.

Lucraft M, Allin K, Batt I. Exploring researcher preference for the version of record. 2021. [cited 24 Jan 2022]. doi: 10.6084/m9.figshare.13834532.v1

Avissar-Whiting M. Downstream retraction of preprinted research in the life and medical sciences. PLoS One 2;17:e0267971, 2022.

Nawabi NLA, Saway BF, Jha R, Pereira M, Mehta NH, Das A, Zukas A, Lindhorst S, Strickland BA. Current trends in the allocation of National Institute of Health funding of brain tumor research. Neurooncol Adv 7:vdae203, 2024.

Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev 29:1304-1312, 2020.

Tolou Ghamari Z. Prevalence and demographic charcteristcs of cancers. CCIJ 9: 13-18, 2020.

Tolou-Ghamari Z, Tadayon F, Mazdak H. Prevalence of liver cancer in Isfahan province, Iran. Indonesian J Cancer 12:56-59, 2018.

Baer A, Bechar N, Cohen G, Devine S. Basic steps to building a research program. J Oncol Pract 6:45-47, 2010.


Refbacks

  • There are currently no refbacks.